Literature DB >> 28256234

Vancomycin Reduces Cell Wall Stiffness and Slows Swim Speed of the Lyme Disease Bacterium.

Michael W Harman1, Alex E Hamby1, Ross Boltyanskiy2, Alexia A Belperron3, Linda K Bockenstedt3, Holger Kress4, Eric R Dufresne2, Charles W Wolgemuth5.   

Abstract

Borrelia burgdorferi, the spirochete that causes Lyme disease, is a tick-transmitted pathogen that requires motility to invade and colonize mammalian and tick hosts. These bacteria use a unique undulating flat-wave shape to penetrate and propel themselves through host tissues. Previous mathematical modeling has suggested that the morphology and motility of these spirochetes depends crucially on the flagellar/cell wall stiffness ratio. Here, we test this prediction using the antibiotic vancomycin to weaken the cell wall. We found that low to moderate doses of vancomycin (≤2.0 μg/mL for 24 h) produced small alterations in cell shape and that as the dose was increased, cell speed decreased. Vancomycin concentrations >1.0 μg/mL also inhibited cell growth and led to bleb formation on a fraction of the cells. To quantitatively assess how vancomycin affects cell stiffness, we used optical traps to bend unflagellated mutants of B. burgdorferi. We found that in the presence of vancomycin, cell wall stiffness gradually decreased over time, with a 40% reduction in the bending stiffness after 36 h. Under the same conditions, the swimming speed of wild-type B. burgdorferi slowed by ∼15%, with only marginal changes to cell morphology. Interestingly, our biophysical model for the swimming dynamics of B. burgdorferi suggested that cell speed should increase with decreasing cell stiffness. We show that this discrepancy can be resolved if the periplasmic volume decreases as the cell wall becomes softer. These results provide a testable hypothesis for how alterations of cell wall stiffness affect periplasmic volume regulation. Furthermore, since motility is crucial to the virulence of B. burgdorferi, the results suggest that sublethal doses of antibiotics could negatively impact spirochete survival by impeding their swim speed, thereby enabling their capture and elimination by phagocytes.
Copyright © 2017 Biophysical Society. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28256234      PMCID: PMC5340155          DOI: 10.1016/j.bpj.2016.12.039

Source DB:  PubMed          Journal:  Biophys J        ISSN: 0006-3495            Impact factor:   4.033


  34 in total

1.  Protection of mice against the Lyme disease agent by immunizing with recombinant OspA.

Authors:  E Fikrig; S W Barthold; F S Kantor; R A Flavell
Journal:  Science       Date:  1990-10-26       Impact factor: 47.728

2.  Borrelia burgdorferi periplasmic flagella have both skeletal and motility functions.

Authors:  M A Motaleb; L Corum; J L Bono; A F Elias; P Rosa; D S Samuels; N W Charon
Journal:  Proc Natl Acad Sci U S A       Date:  2000-09-26       Impact factor: 11.205

3.  Spatiotemporal evolution of erythema migrans, the hallmark rash of Lyme disease.

Authors:  Dhruv K Vig; Charles W Wolgemuth
Journal:  Biophys J       Date:  2014-02-04       Impact factor: 4.033

Review 4.  Doxycycline.

Authors:  B A Cunha; C M Sibley; A M Ristuccia
Journal:  Ther Drug Monit       Date:  1982       Impact factor: 3.681

5.  Structural analysis of the Leptospiraceae and Borrelia burgdorferi by high-voltage electron microscopy.

Authors:  S F Goldstein; K F Buttle; N W Charon
Journal:  J Bacteriol       Date:  1996-11       Impact factor: 3.490

6.  Amoxicillin and potassium clavulanate: an antibiotic combination. Mechanism of action, pharmacokinetics, antimicrobial spectrum, clinical efficacy and adverse effects.

Authors:  D J Weber; N E Tolkoff-Rubin; R H Rubin
Journal:  Pharmacotherapy       Date:  1984 May-Jun       Impact factor: 4.705

7.  Lyme disease testing by large commercial laboratories in the United States.

Authors:  Alison F Hinckley; Neeta P Connally; James I Meek; Barbara J Johnson; Melissa M Kemperman; Katherine A Feldman; Jennifer L White; Paul S Mead
Journal:  Clin Infect Dis       Date:  2014-05-30       Impact factor: 9.079

Review 8.  The penicillin-binding proteins: structure and role in peptidoglycan biosynthesis.

Authors:  Eric Sauvage; Frédéric Kerff; Mohammed Terrak; Juan A Ayala; Paulette Charlier
Journal:  FEMS Microbiol Rev       Date:  2008-02-11       Impact factor: 16.408

9.  In vitro activity of vancomycin against the spirochete Borrelia burgdorferi.

Authors:  L L Dever; J H Jorgensen; A G Barbour
Journal:  Antimicrob Agents Chemother       Date:  1993-05       Impact factor: 5.191

10.  Swimming dynamics of the lyme disease spirochete.

Authors:  Dhruv K Vig; Charles W Wolgemuth
Journal:  Phys Rev Lett       Date:  2012-11-21       Impact factor: 9.161

View more
  3 in total

1.  Identifying Vancomycin as an Effective Antibiotic for Killing Borrelia burgdorferi.

Authors:  Xiaoqian Wu; Bijaya Sharma; Samantha Niles; Kathleen O'Connor; Rebecca Schilling; Nicole Matluck; Anthony D'Onofrio; Linden T Hu; Kim Lewis
Journal:  Antimicrob Agents Chemother       Date:  2018-10-24       Impact factor: 5.191

2.  The unusual cell wall of the Lyme disease spirochaete Borrelia burgdorferi is shaped by a tick sugar.

Authors:  Tanner G DeHart; Mara R Kushelman; Sherry B Hildreth; Richard F Helm; Brandon L Jutras
Journal:  Nat Microbiol       Date:  2021-11-24       Impact factor: 17.745

3.  Adverse reactions of vancomycin in humans: A protocol for meta-analysis.

Authors:  Yang Peng; Chen-Yang Li; Zhi-Ling Yang; Wei Shi
Journal:  Medicine (Baltimore)       Date:  2020-09-18       Impact factor: 1.817

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.